(0.15%) 5 340.75 points
(0.17%) 40 109 points
(0.18%) 18 725 points
(0.57%) $79.08
(-0.12%) $2.41
(0.03%) $2 395.60
(0.46%) $29.87
(1.00%) $1 080.80
(0.04%) $0.919
(0.01%) $10.67
(-0.02%) $0.788
(0.00%) $90.68
Live Chart Being Loaded With Signals
Acacia Pharma Group plc discovers, develops, and commercializes pharmaceutical products for the patients undergoing surgery, invasive procedures, or chemotherapy treatments in the United States and internationally...
Stats | |
---|---|
Today's Volume | 761 376 |
Average Volume | 402 314 |
Market Cap | 0.00 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.396 |
ATR14 | $0 (0.00%) |
Acacia Pharma Group PLC Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Acacia Pharma Group PLC Financials
Annual | 2021 |
Revenue: | $1.16M |
Gross Profit: | $868 000 (74.63 %) |
EPS: | $-0.840 |
FY | 2021 |
Revenue: | $1.16M |
Gross Profit: | $868 000 (74.63 %) |
EPS: | $-0.840 |
FY | 2020 |
Revenue: | $211 000 |
Gross Profit: | $182 000 (86.26 %) |
EPS: | $-0.624 |
FY | 2019 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.430 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Acacia Pharma Group PLC
Acacia Pharma Group plc discovers, develops, and commercializes pharmaceutical products for the patients undergoing surgery, invasive procedures, or chemotherapy treatments in the United States and internationally. The company's lead product is BARHEMSYS, an intravenous amisulpride for the treatment and prophylaxis of post-operative nausea and vomiting. Its products also include BYFAVO, an intravenous remimazolam and reversible IV sedative designed for use during invasive medical procedures, such as colonoscopy and bronchoscopy; and APD403, a selective dopamine antagonist amisulpride that has completed Phase II clinical trials for the treatment of chemotherapy-induced nausea and vomiting. Acacia Pharma Group plc was founded in 2007 and is based in Cambridge, the United Kingdom.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators